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Gastro-intestinal stromal tumours in Hong 
Kong
L E T T E R S  T O
T H E  E D I T O R
To the Editor—We read “Gastro-intestinal stromal 
tumours: a review of current management options”1 
with interest. We wish to point out that, in Hong Kong, 
gastro-intestinal bleeding is the most common presenting 
symptom (60-80% of cases), in contrast to ‘vague 
abdominal mass’ or ‘fullness’ seen in many overseas 
studies.2 Endoscopic ultrasound (EUS) is invaluable in 
the management of gastro-intestinal stromal tumours 
(GISTs) due to its unique ability to reveal detailed tumour 
structures in relation to the adjacent fine bowel wall 
layers. A heterogeneous mass arising from the muscularis 
propria/mucosae with irregular extraluminal margins, 
cystic spaces, and lymph nodes, is highly suggestive 
of a malignant GIST.3 Endoscopic ultrasound–guided 
needle-aspiration biopsy with immunohistology staining 
provides prognostic markers which influence therapeutic 
strategies. Successful EUS-guided endoscopic resection 
of a small GIST has been reported.4 The GIST field was 
revolutionised by the 1998 discovery of c-KIT (CD117 
antigen) as both a diagnostic marker and therapeutic 
target. We observed an increase in the incidence of GIST 
following the introduction of CD117, in both Hong Kong 
and the US.2 In a homogenous population of CD117-
positive GISTs, we are likely to see more consistent data 
regarding survival and treatments from new studies.
 While grossly incomplete tumour removal is an 
established poor prognosticator, lack of data makes it 
difficult to determine optimal strategies for management 
of patients with microscopic involvement of the resection 
margin. In our cohort, survival and tumour recurrence 
rates in patients with microscopic involvement of the 
resection margin resembled those of patients with 
complete tumour resection. Nevertheless, we support 
the author’s comment that the surgeon should attempt 
to obtain microscopically negative margins in any GIST 
with malignant potential.
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